{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T17:59:35Z","timestamp":1773165575217,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,10]]},"DOI":"10.7759\/cureus.53992","type":"journal-article","created":{"date-parts":[[2024,2,11]],"date-time":"2024-02-11T07:10:59Z","timestamp":1707635459000},"source":"Crossref","is-referenced-by-count":2,"title":["Prevalence and Comorbidities Among Individuals With Rheumatoid Arthritis in the Saudi Arabian Context"],"prefix":"10.7759","author":[{"given":"Mushabab","family":"Alghamdi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mansour Y","family":"Somaily","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahenda","family":"Alemam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeed","family":"Majadah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abduaelah Ali H","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah A","family":"Meshary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saad Ahmad A","family":"Alasmri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munif  S","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah A","family":"Alsubaie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elhadi","family":"Miskeen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.246","article-title":"The interplay between inflammation and metabolism in rheumatoid arthritis","volume":"6","author":"Chimenti MS","year":"2015","unstructured":"Chimenti MS, Triggianese P, Conigliaro P, Candi E, Melino G, Perricone R. The interplay between inflammation and metabolism in rheumatoid arthritis. Cell Death Dis. 2015, 6:e1887. 10.1038\/cddis.2015.246","journal-title":"Cell Death Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-022-00827-y","article-title":"Global epidemiology of rheumatoid arthritis","volume":"18","author":"Finckh A","year":"2022","unstructured":"Finckh A, Gilbert B, Hodkinson B, et al.. Global epidemiology of rheumatoid arthritis. Nat Rev Rheumatol. 2022, 18:591-602. 10.1038\/s41584-022-00827-y","journal-title":"Nat Rev Rheumatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1590\/1806-9282.61.02.126","article-title":"Quality of life of patients with rheumatoid arthritis under biological therapy","volume":"61","author":"Azevedo AF","year":"2015","unstructured":"Azevedo AF, Petrib\u00fa KC, Lima Mde N, Silva AS, Rocha Filho Jde A, Mariano MH, Rushansky E. Quality of life of patients with rheumatoid arthritis under biological therapy. Rev Assoc Med Bras (1992). 2015, 61:126-31. 10.1590\/1806-9282.61.02.126","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2702.2002.00624.x","article-title":"Pain and quality of life among older people with rheumatoid arthritis and\/or osteoarthritis: a literature review","volume":"11","author":"Jakobsson U","year":"2002","unstructured":"Jakobsson U, Hallberg IR. Pain and quality of life among older people with rheumatoid arthritis and\/or osteoarthritis: a literature review. J Clin Nurs. 2002, 11:430-43. 10.1046\/j.1365-2702.2002.00624.x","journal-title":"J Clin Nurs"},{"key":"ref5","article-title":"The impact of co-morbidity on health-related quality of life in rheumatoid arthritis and osteoarthritis patients","volume":"33","author":"Geryk LL","year":"2015","unstructured":"Geryk LL, Carpenter DM, Blalock SJ, DeVellis RF, Jordan JM. The impact of co-morbidity on health-related quality of life in rheumatoid arthritis and osteoarthritis patients. Clin Exp Rheumatol. 2015, 33:366-74.","journal-title":"Clin Exp Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10030509","article-title":"The key comorbidities in patients with rheumatoid arthritis: a narrative review","volume":"10","author":"Taylor PC","year":"2021","unstructured":"Taylor PC, Atzeni F, Balsa A, Gossec L, M\u00fcller-Ladner U, Pope J. The key comorbidities in patients with rheumatoid arthritis: a narrative review. J Clin Med. 2021, 10:509. 10.3390\/jcm10030509","journal-title":"J Clin Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/2235042X20920456","article-title":"Comorbidities and their link with individual health status: a cross-sectional analysis of 23,892 people with knee and hip osteoarthritis from primary care","volume":"10","author":"Muckelt PE","year":"2020","unstructured":"Muckelt PE, Roos EM, Stokes M, McDonough S, Gr\u00f8nne DT, Ewings S, Skou ST. Comorbidities and their link with individual health status: a cross-sectional analysis of 23,892 people with knee and hip osteoarthritis from primary care. J Comorb. 2020, 10:2235042X20920456. 10.1177\/2235042X20920456","journal-title":"J Comorb"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102776","article-title":"Rheumatoid arthritis: extra-articular manifestations and comorbidities","volume":"20","author":"Figus FA","year":"2021","unstructured":"Figus FA, Piga M, Azzolin I, McConnell R, Iagnocco A. Rheumatoid arthritis: extra-articular manifestations and comorbidities. Autoimmun Rev. 2021, 20:102776. 10.1016\/j.autrev.2021.102776","journal-title":"Autoimmun Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102735","article-title":"Beyond the joints, the extra-articular manifestations in rheumatoid arthritis","volume":"20","author":"Conforti A","year":"2021","unstructured":"Conforti A, Di Cola I, Pavlych V, et al.. Beyond the joints, the extra-articular manifestations in rheumatoid arthritis. Autoimmun Rev. 2021, 20:102735. 10.1016\/j.autrev.2020.102735","journal-title":"Autoimmun Rev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.899372","article-title":"Preclinical autoimmune disease: a comparison of rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis and type 1 diabetes","volume":"13","author":"Frazzei G","year":"2022","unstructured":"Frazzei G, van Vollenhoven RF, de Jong BA, Siegelaar SE, van Schaardenburg D. Preclinical autoimmune disease: a comparison of rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis and type 1 diabetes. Front Immunol. 2022, 13:899372. 10.3389\/fimmu.2022.899372","journal-title":"Front Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-022-00814-3","article-title":"How does age determine the development of human immune-mediated arthritis?","volume":"18","author":"Degboe Y","year":"2022","unstructured":"Degboe Y, Vastert SJ, Prakken BJ, McInnes IB. How does age determine the development of human immune-mediated arthritis?. Nat Rev Rheumatol. 2022, 18:501-12. 10.1038\/s41584-022-00814-3","journal-title":"Nat Rev Rheumatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/wps.21110","article-title":"Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management","volume":"22","author":"Berk M","year":"2023","unstructured":"Berk M, K\u00f6hler-Forsberg O, Turner M, et al.. Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management. World Psychiatry. 2023, 22:366-87. 10.1002\/wps.21110","journal-title":"World Psychiatry"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.52533\/JOHS.2023.30707","article-title":"Adrenal insufficiency in patients with rheumatoid arthritis: prevalence, clinical implications, and management strategies","volume":"3","author":"Al Jehani M","year":"2023","unstructured":"Al Jehani M, Almagsoodi A, Al Junaybi A, et al.. Adrenal insufficiency in patients with rheumatoid arthritis: prevalence, clinical implications, and management strategies. J Health Sci. 2023, 3:235-40. 10.52533\/JOHS.2023.30707","journal-title":"J Health Sci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.21r14328","article-title":"Impact of major depressive disorder on comorbidities: a systematic literature review","volume":"83","author":"Arnaud AM","year":"2022","unstructured":"Arnaud AM, Brister TS, Duckworth K, et al.. Impact of major depressive disorder on comorbidities: a systematic literature review. J Clin Psychiatry. 2022, 83:43390. 10.4088\/JCP.21r14328","journal-title":"J Clin Psychiatry"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-20176-w","article-title":"Identifying pre-existing conditions and multimorbidity patterns associated with in-hospital mortality in patients with COVID-19","volume":"12","author":"Bucholc M","year":"2022","unstructured":"Bucholc M, Bradley D, Bennett D, et al.. Identifying pre-existing conditions and multimorbidity patterns associated with in-hospital mortality in patients with COVID-19. Sci Rep. 2022, 12:17313. 10.1038\/s41598-022-20176-w","journal-title":"Sci Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s41927-022-00267-x","article-title":"Development of an interdisciplinary early rheumatoid arthritis care pathway","volume":"6","author":"Gukova X","year":"2022","unstructured":"Gukova X, Hazlewood GS, Arbillaga H, et al.. Development of an interdisciplinary early rheumatoid arthritis care pathway. BMC Rheumatol. 2022, 6:35. 10.1186\/s41927-022-00267-x","journal-title":"BMC Rheumatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.45578","article-title":"Advancements in myocardial infarction management: exploring novel approaches and strategies","volume":"15","author":"Sachdeva P","year":"2023","unstructured":"Sachdeva P, Kaur K, Fatima S, et al.. Advancements in myocardial infarction management: exploring novel approaches and strategies. Cureus. 2023, 15:e45578. 10.7759\/cureus.45578","journal-title":"Cureus"},{"key":"ref18","article-title":"Highlights from Middle East Rheumatology Conference: Middle East Rheumatology Conference of the Gulf Cooperation Council Association of Immunology and Rheumatology, November 25- 27, 2021 Dubai, United Arab Emirates","volume":"43","author":"Zayat A","year":"2022","unstructured":"Zayat A, Namas R, AlOkaily F, et al.. Highlights from Middle East Rheumatology Conference: Middle East Rheumatology Conference of the Gulf Cooperation Council Association of Immunology and Rheumatology, November 25- 27, 2021 Dubai, United Arab Emirates. Saudi Med J. 2022, 43:637-55.","journal-title":"Saudi Med J"},{"key":"ref19","article-title":"Epidemiology and socioeconomic burden of osteoarthritis","volume":"8","author":"Alkady EA","year":"2023","unstructured":"Alkady EA, Selim ZI, Abdelaziz MM, El-Hafeez FA. Epidemiology and socioeconomic burden of osteoarthritis. Journal of Current Medical Research and Practice. 2023, 8:7-11.","journal-title":"Journal of Current Medical Research and Practice"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12041291","article-title":"The burden of rheumatoid arthritis: findings from the 2019 Global Burden of Diseases Study and forecasts for 2030 by Bayesian age-period-cohort analysis","volume":"12","author":"Cai Y","year":"2023","unstructured":"Cai Y, Zhang J, Liang J, et al.. The burden of rheumatoid arthritis: findings from the 2019 Global Burden of Diseases Study and forecasts for 2030 by Bayesian age-period-cohort analysis. J Clin Med. 2023, 12:1291. 10.3390\/jcm12041291","journal-title":"J Clin Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.14295","article-title":"The burden of illness of rheumatoid arthritis in Latin America-a systematic literature review","volume":"25","author":"Papadimitropoulos E","year":"2022","unstructured":"Papadimitropoulos E, Brnabic A, Vorstenbosch E, Leonardi F, Moyano S, Gomez D. The burden of illness of rheumatoid arthritis in Latin America-a systematic literature review. Int J Rheum Dis. 2022, 25:405-21. 10.1111\/1756-185X.14295","journal-title":"Int J Rheum Dis"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19053088","article-title":"Sexual dysfunction and quality of life in patients with rheumatoid arthritis","volume":"19","author":"Ta\u0144ski W","year":"2022","unstructured":"Ta\u0144ski W, Dudek K, Tomasiewicz A, \u015awi\u0105toniowska-Lonc N. Sexual dysfunction and quality of life in patients with rheumatoid arthritis. Int J Environ Res Public Health. 2022, 19:3088. 10.3390\/ijerph19053088","journal-title":"Int J Environ Res Public Health"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac584","article-title":"Comorbidities and extra-articular manifestations in difficult-to-treat rheumatoid arthritis: different sides of the same coin?","volume":"62","author":"Dey M","year":"2023","unstructured":"Dey M, Nagy G, Nikiphorou E. Comorbidities and extra-articular manifestations in difficult-to-treat rheumatoid arthritis: different sides of the same coin?. Rheumatology (Oxford). 2023, 62:1773-9. 10.1093\/rheumatology\/keac584","journal-title":"Rheumatology (Oxford)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21710","article-title":"Association of obesity with worse disease severity in rheumatoid arthritis as well as with comorbidities: a long-term followup from disease onset","volume":"65","author":"Ajeganova S","year":"2013","unstructured":"Ajeganova S, Andersson ML, Hafstr\u00f6m I. Association of obesity with worse disease severity in rheumatoid arthritis as well as with comorbidities: a long-term followup from disease onset. Arthritis Care Res (Hoboken). 2013, 65:78-87. 10.1002\/acr.21710","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1006290","article-title":"Association of rheumatoid arthritis with bronchial asthma and asthma-related comorbidities: a population-based national surveillance study","volume":"10","author":"Kim JG","year":"2023","unstructured":"Kim JG, Kang J, Lee JH, Koo HK. Association of rheumatoid arthritis with bronchial asthma and asthma-related comorbidities: a population-based national surveillance study. Front Med (Lausanne). 2023, 10:1006290. 10.3389\/fmed.2023.1006290","journal-title":"Front Med (Lausanne)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59081446","article-title":"Assessment and prediction of adherence to methotrexate using three self-report questionnaires in patients with rheumatoid arthritis","volume":"59","author":"Ceranic J","year":"2023","unstructured":"Ceranic J, Kisic Tepavcevic D, Petronijevic M, Milic M, Ceranic M, Rancic N, Ristic G. Assessment and prediction of adherence to methotrexate using three self-report questionnaires in patients with rheumatoid arthritis. Medicina (Kaunas). 2023, 59:1446. 10.3390\/medicina59081446","journal-title":"Medicina (Kaunas)"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2023.1184720","article-title":"Effect of type of disease-modifying antirheumatic drugs on depression and anxiety of patients with rheumatoid arthritis in Saudi Arabia: a cross-sectional study","volume":"14","author":"Baghdadi LR","year":"2023","unstructured":"Baghdadi LR, Alhassan MK, Alotaibi FH, Alsuwaida AA, Shehadah AE, Alzahrani MT. Effect of type of disease-modifying antirheumatic drugs on depression and anxiety of patients with rheumatoid arthritis in Saudi Arabia: a cross-sectional study. Front Psychiatry. 2023, 14:1184720. 10.3389\/fpsyt.2023.1184720","journal-title":"Front Psychiatry"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000033151","article-title":"Prevalence of fatigue functional and social impairment among patients with rheumatic diseases compared to patients without: a cross-sectional comparison","volume":"102","author":"Almalag HM","year":"2023","unstructured":"Almalag HM, Almaghlouth I, Dabbagh R, et al.. Prevalence of fatigue functional and social impairment among patients with rheumatic diseases compared to patients without: a cross-sectional comparison. Medicine (Baltimore). 2023, 102:e33151. 10.1097\/MD.0000000000033151","journal-title":"Medicine (Baltimore)"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.hsr.2023.100108","article-title":"Association of cardiovascular risks in rheumatoid arthritis patients: management, treatment and future perspectives","volume":"8","author":"Johri N","year":"2023","unstructured":"Johri N, Varshney S, Gandha S, et al.. Association of cardiovascular risks in rheumatoid arthritis patients: management, treatment and future perspectives. Health Sciences Review. 2023, 8:100108. 10.1016\/j.hsr.2023.100108","journal-title":"Health Sciences Review"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1111\/jcpe.13826","article-title":"Increased risk of periodontitis in patients with rheumatoid arthritis: a nationwide register study in Norway","volume":"50","author":"Bolstad AI","year":"2023","unstructured":"Bolstad AI, Fevang BS, Lie SA. Increased risk of periodontitis in patients with rheumatoid arthritis: a nationwide register study in Norway. J Clin Periodontol. 2023, 50:1022-32. 10.1111\/jcpe.13826","journal-title":"J Clin Periodontol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-022-04492-3","article-title":"Rheumatoid arthritis: advances in treatment strategies","volume":"478","author":"Prasad P","year":"2023","unstructured":"Prasad P, Verma S, Surbhi, Ganguly NK, Chaturvedi V, Mittal SA. Rheumatoid arthritis: advances in treatment strategies. Mol Cell Biochem. 2023, 478:69-88. 10.1007\/s11010-022-04492-3","journal-title":"Mol Cell Biochem"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-022-06478-4","article-title":"Real-world patient characteristics and use of disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis: a cross-national study","volume":"42","author":"Ingrasciotta Y","year":"2023","unstructured":"Ingrasciotta Y, Jin Y, Foti SS, et al.. Real-world patient characteristics and use of disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis: a cross-national study. Clin Rheumatol. 2023, 42:1047-59. 10.1007\/s10067-022-06478-4","journal-title":"Clin Rheumatol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1097\/01.JAA.0000937316.70181.ff","article-title":"Treating rheumatoid arthritis","volume":"36","author":"Korol I","year":"2023","unstructured":"Korol I, Baumeister RH. Treating rheumatoid arthritis. JAAPA. 2023, 36:1-5. 10.1097\/01.JAA.0000937316.70181.ff","journal-title":"JAAPA"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223365","article-title":"Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis","volume":"82","author":"Kerschbaumer A","year":"2023","unstructured":"Kerschbaumer A, Sepriano A, Bergstra SA, et al.. Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis. 2023, 82:95-106. 10.1136\/ard-2022-223365","journal-title":"Ann Rheum Dis"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.46290","article-title":"Methotrexate-induced mucositis: a consequence of medication error in a rheumatoid arthritis patient","volume":"15","author":"Shrestha R","year":"2023","unstructured":"Shrestha R, Ojha SK, Jha SK, Jasraj R, Fauzdar A. Methotrexate-induced mucositis: a consequence of medication error in a rheumatoid arthritis patient. Cureus. 2023, 15:e46290. 10.7759\/cureus.46290","journal-title":"Cureus"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-023-00800-3","article-title":"Strategic use of levofolinic acid for methotrexate-induced side effects in juvenile idiopathic arthritis: a prospective observational study","volume":"21","author":"Martini G","year":"2023","unstructured":"Martini G, Meneghel A, Fastiggi M, Dell'Apa F, Vittadello F, Zulian F. Strategic use of levofolinic acid for methotrexate-induced side effects in juvenile idiopathic arthritis: a prospective observational study. Pediatr Rheumatol Online J. 2023, 21:18. 10.1186\/s12969-023-00800-3","journal-title":"Pediatr Rheumatol Online J"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.40580","article-title":"Hypoplastic myelodysplastic syndrome: symptom of methotrexate toxicity in rheumatoid arthritis","volume":"15","author":"Khan A","year":"2023","unstructured":"Khan A, Anwar M, Azam A, Nisar S, Rehman AU. Hypoplastic myelodysplastic syndrome: symptom of methotrexate toxicity in rheumatoid arthritis. Cureus. 2023, 15:e40580. 10.7759\/cureus.40580","journal-title":"Cureus"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.29518","article-title":"Overview of methotrexate toxicity: a comprehensive literature review","volume":"14","author":"Hamed KM","year":"2022","unstructured":"Hamed KM, Dighriri IM, Baomar AF, et al.. Overview of methotrexate toxicity: a comprehensive literature review. Cureus. 2022, 14:e29518. 10.7759\/cureus.29518","journal-title":"Cureus"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20225552","article-title":"Wnt signaling and biological therapy in rheumatoid arthritis and spondyloarthritis","volume":"20","author":"Cici D","year":"2019","unstructured":"Cici D, Corrado A, Rotondo C, Cantatore FP. Wnt signaling and biological therapy in rheumatoid arthritis and spondyloarthritis. Int J Mol Sci. 2019, 20:5552. 10.3390\/ijms20225552","journal-title":"Int J Mol Sci"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.809806","article-title":"Apoptosis, autophagy, NETosis, necroptosis, and pyroptosis mediated programmed cell death as targets for innovative therapy in rheumatoid arthritis","volume":"12","author":"Zhao J","year":"2021","unstructured":"Zhao J, Jiang P, Guo S, Schrodi SJ, He D. Apoptosis, autophagy, NETosis, necroptosis, and pyroptosis mediated programmed cell death as targets for innovative therapy in rheumatoid arthritis. Front Immunol. 2021, 12:809806. 10.3389\/fimmu.2021.809806","journal-title":"Front Immunol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01789-0","article-title":"Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial","volume":"28","author":"Rivellese F","year":"2022","unstructured":"Rivellese F, Surace AE, Goldmann K, et al.. Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial. Nat Med. 2022, 28:1256-68. 10.1038\/s41591-022-01789-0","journal-title":"Nat Med"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102442","article-title":"Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy","volume":"109","author":"Ceribelli A","year":"2020","unstructured":"Ceribelli A, Motta F, De Santis M, Ansari AA, Ridgway WM, Gershwin ME, Selmi C. Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy. J Autoimmun. 2020, 109:102442. 10.1016\/j.jaut.2020.102442","journal-title":"J Autoimmun"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-020-00933-4","article-title":"The impact of obesity on disease activity and treatment response in rheumatoid arthritis","volume":"22","author":"Poudel D","year":"2020","unstructured":"Poudel D, George MD, Baker JF. The impact of obesity on disease activity and treatment response in rheumatoid arthritis. Curr Rheumatol Rep. 2020, 22:56. 10.1007\/s11926-020-00933-4","journal-title":"Curr Rheumatol Rep"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-021-01025-7","article-title":"Current epidemiology and risk factors for the development of hand osteoarthritis","volume":"23","author":"Plotz B","year":"2021","unstructured":"Plotz B, Bomfim F, Sohail MA, Samuels J. Current epidemiology and risk factors for the development of hand osteoarthritis. Curr Rheumatol Rep. 2021, 23:61. 10.1007\/s11926-021-01025-7","journal-title":"Curr Rheumatol Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/219830-prevalence-and-comorbidities-among-individuals-with-rheumatoid-arthritis-in-the-saudi-arabian-context","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,11]],"date-time":"2024-02-11T07:11:02Z","timestamp":1707635462000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/219830-prevalence-and-comorbidities-among-individuals-with-rheumatoid-arthritis-in-the-saudi-arabian-context"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,10]]},"references-count":44,"URL":"https:\/\/doi.org\/10.7759\/cureus.53992","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,10]]}}}